secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0001437749-25-011030
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia: Nasdaq notice for equity $837K vs $2.5M minimum; plan due May 16
---------------------------------------------------------------------------

- Stockholders' equity of $837K as of Dec 31, 2024 is below Nasdaq's $2.5M minimum for continued listing.
- Company must submit a compliance plan by May 16, 2025; Nasdaq may grant up to 180-day extension.
- No immediate effect on trading; common stock continues on Nasdaq Capital Market under BCDA.
- Company intends to submit a plan; risk of delisting if plan rejected or not accepted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774925011030/0001437749-25-011030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774925011030/bcda20250401_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-011030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer